Exact Mass: 700.2969006000001
Exact Mass Matches: 700.2969006000001
Found 100 metabolites which its exact mass value is equals to given mass value 700.2969006000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Catheduline E2
C38H40N2O11 (700.2631970000001)
Posaconazole
C37H42F2N8O4 (700.3296915999999)
Posaconazole is only found in individuals that have used or taken this drug. It is a triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients.As a triazole antifungal agent, posaconazole exerts its antifungal activity through blockage of the cytochrome P-450 dependent enzyme, sterol 14alpha-demethylase, in fungi by binding to the heme cofactor located on the enzyme. This leads to the inhibition of the synthesis of ergosterol, a key component of the fungal cell membrane, and accumulation of methylated sterol precursors. This results in inhibition of fungal cell growth and ultimately, cell death.
Pentacarboxyl porphyrinogen III
Substrate for erythrocyte uroporphyrinogen decarboxylase in patients with porphyria cutanea tarda (PubNed ID 1610684 ) [HMDB] Substrate for erythrocyte uroporphyrinogen decarboxylase in patients with porphyria cutanea tarda (PubNed ID 1610684 ).
Tyr-D-thr-gly-phe-leu-thr
(7R,8R)-4,9-bis(beta-D-glucopyranosyloxy)-3,3-dimethoxy-8,4-oxyneolign-7-ene-7,9-diol|3-{4-{(1R,2R)-2-[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]-2-hydroxy-1-(hydroxymethyl)ethoxy}-3-methoxyphenyl}prop-2-enyl beta-D-glucopyranoside|ligusinenoside B|ligusinenoside B
(3aS,4S,6aR,7R,8aS,9aS,10aS,11R,11aR,12S,13R,13aR)-7,11,12,13-tetrakis(acetyloxy)-3a,4,6a,6b,6c,7,8a,9,9a,10a,11,11a,11b,12,13,13a,13b,13c-octadecahydro-4-hydroxy-1,3a,4,11a,13a-pentamethyl-3H-oxireno[6,7]naphtho[1,2:7,8]fluoreno[9,1-bc]pyran-3,5,8-trione|taccalonolide X
12-(2-Methylbutanoyl),1,7,11-tri-Ac,Me ester-1,3,7,11,12-Pentahydroxy-14-meliacen-28-oic acid|28-nor-4alpha-carbomethoxy-11beta-acetoxy-12alpha-(2-methylbutanoyloxy)-14,15-deoxyhavanensin-1,7-diacetate
rel-(2S,3S,4E,6S,7R,8R,9S,11E,13S,14S,15R)-7,8,9,14,15-pentaacetoxy-3-(benzoyloxy)-6-hydroxyjatropha-4,11-diene
tri-O-methyl-3-O-acetylrobinetinidol-(4beta2)-3,4,5,7-tetra-methoxyflavone
Me glycoside,2,3,3,4,6-pentabenzyl-Pyranose-2-O-alpha-L-Rhamnopyranosyl-D-galactose
9-O-[6-O-(5-O-syringoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-(5R,6S,9R,7E)-6,9-dihydroxymegastigman-3-on-7-ene|obtusifoside H
Bipindogenin-3-O-??-D-xylopyranosyl(1鈥樏傗垎4)-??-D-allopyranoside
Posaconazole
C37H42F2N8O4 (700.3296915999999)
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3_,5_,15_-O-triacetoxy-7_-14_-O-dibenzoyloxymyrsinol
Phe Trp Trp Tyr
C40H40N6O6 (700.3009180000001)
Phe Trp Tyr Trp
C40H40N6O6 (700.3009180000001)
Phe Tyr Trp Trp
C40H40N6O6 (700.3009180000001)
Trp Phe Trp Tyr
C40H40N6O6 (700.3009180000001)
Trp Phe Tyr Trp
C40H40N6O6 (700.3009180000001)
Trp Trp Phe Tyr
C40H40N6O6 (700.3009180000001)
Trp Trp Tyr Phe
C40H40N6O6 (700.3009180000001)
Trp Tyr Phe Trp
C40H40N6O6 (700.3009180000001)
Trp Tyr Trp Phe
C40H40N6O6 (700.3009180000001)
Tyr Phe Trp Trp
C40H40N6O6 (700.3009180000001)
Tyr Trp Phe Trp
C40H40N6O6 (700.3009180000001)
Tyr Trp Trp Phe
C40H40N6O6 (700.3009180000001)
N-dodecanoyl-L-HSL-3-hydrazone-fluorescein
C37H40N4O8S (700.2566720000001)
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
C37H42F2N8O4 (700.3296915999999)
2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2R)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
C37H42F2N8O4 (700.3296915999999)
1,4-Anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[4-[4-[4-[1-[(1S,2R)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-D-erythro-pentitol
C37H42F2N8O4 (700.3296915999999)
1,3-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene
2-Deoxy-fucosyl-rhodosaminyl-aklavinone
C36H46NO13+ (700.2969006000001)
D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Peritol
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents
(-)-(7S,8S)-threo-carolignan X
A natural product found in Durio carinatus.
(-)-(7R,8S)-erythro-carolignan X
A natural product found in Durio carinatus and Durio oxleyanus.
N-[(3S,9S,10R)-9-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-4-isoxazolesulfonamide
1-[(3S,9R,10S)-9-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
C35H45ClN4O7S (700.2697330000001)
[(1R,2R,3aR,5S,6E,9S,10S,11S,13R,13aS)-1,9,10-triacetyloxy-2,3a-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-13-(2-methylpropanoyloxy)-4-oxo-1,3,5,9,10,11,13,13a-octahydrocyclopenta[12]annulen-11-yl] benzoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[(1R,2R,3aR,5S,6E,9S,10S,11S,13R,13aS)-1,2,9-triacetyloxy-3a,10-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-11-(2-methylpropanoyloxy)-4-oxo-1,3,5,9,10,11,13,13a-octahydrocyclopenta[12]annulen-13-yl] benzoate
(1s,2r,4s,5r,6s,8e,10s,12s,14r,15r)-5,6,15-tris(acetyloxy)-12,14-dihydroxy-7,7,10,14-tetramethyl-3-methylidene-11,16-dioxo-4-phenoxybicyclo[10.3.1]hexadec-8-en-2-yl 2-methylpropanoate
[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-4-({[(2r)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoyl]oxy}methyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl]methyl 3-(acetyloxy)-3-methylbutanoate
(2s,3s,4s,5s,6s)-4,5-dihydroxy-6-{[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-2-(6-hydroxypurin-9-yl)oxolan-3-yl]oxy}-2-methyloxan-3-yl (2e,4e,7z,9s)-9-[(2z,4z)-octa-2,4-dienoyloxy]deca-2,4,7-trienoate
(2s,3s,4s,5s,6s)-4,5-dihydroxy-6-{[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-2-(6-hydroxypurin-9-yl)oxolan-3-yl]oxy}-2-methyloxan-3-yl (2e,4e,7z,9s)-9-[(2e,4z)-octa-2,4-dienoyloxy]deca-2,4,7-trienoate
(7r,8s,10r)-10-{[(2r,4r,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-7-{[(2s,4r,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
C36H48N2O12 (700.3207087999999)